| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.39e-08 | 18 | 246 | 6 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 IQCA1L TOR1B DDX60L DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 DNAH12 ENTPD1 ATP2B2 | 9.85e-06 | 441 | 246 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.12e-05 | 28 | 246 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 IQCA1L TOR1B DDX60L KIFC3 DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 ATP6V1E2 DNAH12 DNAH17 ENTPD1 ATP2B2 | 2.59e-05 | 614 | 246 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity | MAOB ALDH1L1 SQOR PTGS1 NDUFS3 PHYH DUOX1 FASN PXDN SUOX FADS2 ALOX12 VCAM1 ACAD9 GPX5 COX7A1 COX7A2P2 IDH2 MOXD1 MTHFD1 EHHADH OGDHL SORD | 7.96e-05 | 766 | 246 | 23 | GO:0016491 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.61e-05 | 37 | 246 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 IQCA1L GBP4 GBP5 RAB43 TOR1B DDX60L DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 DNAH12 ENTPD1 EIF5B ATP2B2 RHOT1 | 9.48e-05 | 775 | 246 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 NUDT12 IQCA1L GBP4 GBP5 RAB43 TOR1B DDX60L DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 DNAH12 ENTPD1 EIF5B ATP2B2 RHOT1 | 1.17e-04 | 839 | 246 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 NUDT12 IQCA1L GBP4 GBP5 RAB43 TOR1B DDX60L DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 DNAH12 ENTPD1 EIF5B ATP2B2 RHOT1 | 1.19e-04 | 840 | 246 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ERCC2 HSP90AB4P MYO9B PSMC3 MCM7 ABCB1 HSPA13 NUDT12 IQCA1L GBP4 GBP5 RAB43 TOR1B DDX60L DNAH5 DNAH6 PMS1 ATP8B3 DNAH10 DNAH12 ENTPD1 EIF5B ATP2B2 RHOT1 | 1.19e-04 | 840 | 246 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.23e-04 | 70 | 246 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | phosphatidylinositol trisphosphate phosphatase activity | 2.83e-04 | 11 | 246 | 3 | GO:0034594 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 4.79e-04 | 30 | 246 | 4 | GO:0052866 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.54e-04 | 118 | 246 | 7 | GO:0003774 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.13e-06 | 25 | 244 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 7.57e-05 | 20 | 244 | 4 | GO:0016010 | |
| GeneOntologyCellularComponent | sarcolemma | 8.28e-05 | 190 | 244 | 10 | GO:0042383 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.77e-04 | 10 | 244 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | glycoprotein complex | 1.89e-04 | 25 | 244 | 4 | GO:0090665 | |
| GeneOntologyCellularComponent | dynein complex | 4.13e-04 | 54 | 244 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | WASH complex | 6.44e-04 | 15 | 244 | 3 | GO:0071203 | |
| GeneOntologyCellularComponent | axoneme | 7.57e-04 | 207 | 244 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.84e-04 | 208 | 244 | 9 | GO:0097014 | |
| Domain | K_chnl_volt-dep_ERG | 2.20e-06 | 3 | 244 | 3 | IPR003967 | |
| Domain | ATPase_dyneun-rel_AAA | 2.57e-05 | 14 | 244 | 4 | IPR011704 | |
| Domain | AAA_8 | 2.57e-05 | 14 | 244 | 4 | PF12780 | |
| Domain | AAA_5 | 2.57e-05 | 14 | 244 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.57e-05 | 14 | 244 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.57e-05 | 14 | 244 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.57e-05 | 14 | 244 | 4 | PF08393 | |
| Domain | DHC_fam | 3.46e-05 | 15 | 244 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.46e-05 | 15 | 244 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.46e-05 | 15 | 244 | 4 | IPR004273 | |
| Domain | Dystrophin | 1.70e-04 | 2 | 244 | 2 | IPR016344 | |
| Domain | FAM21 | 1.70e-04 | 2 | 244 | 2 | IPR027308 | |
| Domain | Haem_peroxidase | 2.47e-04 | 10 | 244 | 3 | IPR010255 | |
| Domain | - | 2.47e-04 | 10 | 244 | 3 | 1.10.640.10 | |
| Domain | An_peroxidase | 2.47e-04 | 10 | 244 | 3 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.47e-04 | 10 | 244 | 3 | IPR019791 | |
| Domain | PAS_9 | 2.47e-04 | 10 | 244 | 3 | PF13426 | |
| Domain | PEROXIDASE_3 | 2.47e-04 | 10 | 244 | 3 | PS50292 | |
| Domain | - | 3.96e-04 | 48 | 244 | 5 | 2.60.120.10 | |
| Domain | CAP-ZIP_m | 5.06e-04 | 3 | 244 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 5.06e-04 | 3 | 244 | 2 | IPR029341 | |
| Domain | RmlC-like_jellyroll | 5.26e-04 | 51 | 244 | 5 | IPR014710 | |
| Domain | CYTOCHROME_B5_1 | 5.72e-04 | 13 | 244 | 3 | PS00191 | |
| Domain | CYTOCHROME_B5_2 | 5.72e-04 | 13 | 244 | 3 | PS50255 | |
| Domain | AAA+_ATPase | 6.19e-04 | 144 | 244 | 8 | IPR003593 | |
| Domain | AAA | 6.19e-04 | 144 | 244 | 8 | SM00382 | |
| Domain | Cyt-b5 | 7.21e-04 | 14 | 244 | 3 | PF00173 | |
| Domain | - | 7.21e-04 | 14 | 244 | 3 | 3.10.120.10 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 7.21e-04 | 14 | 244 | 3 | IPR003938 | |
| Domain | MT | 7.21e-04 | 14 | 244 | 3 | PF12777 | |
| Domain | Dynein_HC_stalk | 7.21e-04 | 14 | 244 | 3 | IPR024743 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 7.21e-04 | 14 | 244 | 3 | IPR001199 | |
| Domain | Cyt-b5 | 7.21e-04 | 14 | 244 | 3 | SM01117 | |
| Domain | CNMP_BINDING_1 | 7.67e-04 | 32 | 244 | 4 | PS00888 | |
| Domain | CNMP_BINDING_2 | 7.67e-04 | 32 | 244 | 4 | PS00889 | |
| Domain | cNMP | 9.69e-04 | 34 | 244 | 4 | SM00100 | |
| Domain | cNMP_binding | 9.69e-04 | 34 | 244 | 4 | PF00027 | |
| Domain | Cyt_c_oxidase_su7a | 1.00e-03 | 4 | 244 | 2 | IPR003177 | |
| Domain | Sarcoglycan_1 | 1.00e-03 | 4 | 244 | 2 | PF04790 | |
| Domain | Sarcoglycan | 1.00e-03 | 4 | 244 | 2 | IPR006875 | |
| Domain | TPR-like_helical_dom | DELE1 TRANK1 SMG6 OGT POLR1A TEX11 TTC21B TANC1 PRKDC DNAJC3 | 1.02e-03 | 233 | 244 | 10 | IPR011990 |
| Domain | cNMP-bd_dom | 1.08e-03 | 35 | 244 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.08e-03 | 35 | 244 | 4 | PS50042 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9B ACP1 SNX17 PSMC3 MCM7 URB2 DDB1 NDUFS3 MPRIP FASN NF1 ADSS2 UBE3A GLS DDX60L HERC2 MVP UTRN DNAJC13 GNL3L POLR1A FERMT1 POLR2H TGM2 MTHFD1 PA2G4 EIF5B TANC1 PRKDC WDFY3 EXOC2 SORD | 3.17e-09 | 1353 | 248 | 32 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 MYO9B NAGLU WASHC2A MPRIP FASN KCNH2 RAB43 KIFC3 HERC2 DOCK6 PREX1 RIC1 SMG6 VPS39 INPP5E RNPEPL1 REV3L VAC14 CSNK1G2 NISCH KANK3 ANKRD11 OGDHL TANC1 POFUT1 PRKDC WDFY3 | 7.71e-09 | 1105 | 248 | 28 | 35748872 |
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 9373155 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ADAM9 PSMC3 URB2 NDUFS3 FASN PXDN UBE3A KPNA2 GNL3L POLR1A DNAJC16 ACAD9 SLC19A2 SAMHD1 GSK3A SACM1L ARFGEF3 VAC14 PA2G4 NISCH DDRGK1 POFUT1 PRKDC DNAJC3 | 8.77e-08 | 942 | 248 | 24 | 31073040 |
| Pubmed | TEX2 SNX17 WASHC2A CEMIP2 FADS2 DOCK6 RIC1 DNAJC13 WASHC2C DNAJC16 PIGU ARFGEF3 VAC14 NISCH DDRGK1 AKAP11 VPS13B | 1.58e-07 | 504 | 248 | 17 | 34432599 | |
| Pubmed | FRMPD4 ADAM9 URB2 WASHC2A ZEB2 PXDN PCDH19 WASHC2C DNAJC16 SACM1L ARFGEF3 GCC2 NISCH RERE VPS13B | 2.83e-07 | 407 | 248 | 15 | 12693553 | |
| Pubmed | MYO9B PSMC3 MCM7 FASN NF1 GBP5 FADS2 HERC2 MVP KPNA2 DNAJC13 GNL3L CALR PIGU MTHFD1 PA2G4 CSNK1G2 GCC2 NISCH ENTPD1 POFUT1 PRKDC EXOC2 DNAJC3 IL6ST RHOT1 | 3.40e-07 | 1168 | 248 | 26 | 19946888 | |
| Pubmed | Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome. | 3.58e-07 | 3 | 248 | 3 | 35818223 | |
| Pubmed | HERG K(+) currents in human prolactin-secreting adenoma cells. | 3.58e-07 | 3 | 248 | 3 | 12634931 | |
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 14643686 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ERCC2 ACP1 PSMC3 MCM7 URB2 NDUFS3 FASN UBE3A DNAH5 POLR1A NELFB SAMHD1 IDH2 SACM1L PA2G4 PRKDC DNAJC3 RHOT1 SORD | 8.78e-07 | 704 | 248 | 19 | 29955894 |
| Pubmed | ERCC4 TEX2 CD2AP ESRP1 ASH1L WASHC2A GBP4 UTRN PLXNB1 ZWILCH OGT WASHC2C NRDC VPS39 INPP5E ACAD9 WDFY4 RESF1 MTHFD1 PA2G4 VCAN OGDHL ROCK1 VPS13B | 1.08e-06 | 1084 | 248 | 24 | 11544199 | |
| Pubmed | TPTE PCGF2 ADAM9 BMI1 KCNH6 ADSS2 KCNH2 RPS6KA6 PLCB3 DNAH5 ATP8B3 GNL3L DNAH10 GSK3A SACM1L TGM2 MTHFD1 DNAH17 ENTPD1 | 1.50e-06 | 730 | 248 | 19 | 34857952 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 20541997 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TEX2 POLA2 NLN PTPN4 KIFC3 PPIP5K2 SMG6 KPNA2 DNAJC13 MTHFD1 CSNK1G2 KANK3 ANKRD11 TANC1 RERE WDFY3 | 1.82e-06 | 536 | 248 | 16 | 15840001 |
| Pubmed | TEX2 POLA2 NLN PTPN4 KIFC3 PPIP5K2 SMG6 KPNA2 DNAJC13 MTHFD1 CSNK1G2 KANK3 ANKRD11 TANC1 RERE WDFY3 | 1.91e-06 | 538 | 248 | 16 | 10512203 | |
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 2.18e-06 | 30 | 248 | 5 | 34017080 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | DIS3L ADAM9 NAGLU URB2 POLA2 DDB1 UBE3A FADS2 HERC2 DOCK6 KPNA2 CALR VPS39 ACAD9 SLC19A2 ZWINT DTWD2 GCC2 POFUT1 | 2.40e-06 | 754 | 248 | 19 | 33060197 |
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 2.45e-06 | 84 | 248 | 7 | 19237606 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 3.10e-06 | 87 | 248 | 7 | 17148452 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | ERG ADAM9 PSMC3 SQOR UBE3A FADS2 DNAJC13 CALR SGCD DNAJC16 PTPN21 PIGU MBIP SACM1L RHOT1 | 3.54e-06 | 499 | 248 | 15 | 22810586 |
| Pubmed | ERCC4 ADAM9 CEMIP2 PLCB3 PPIP5K2 PLXNB1 RIC1 PMS1 GNL3L OGT NRDC DNAJC16 SACM1L TGM2 NISCH TANC1 RHOT1 | 5.07e-06 | 650 | 248 | 17 | 38777146 | |
| Pubmed | MYO9B MCM7 URB2 MPRIP FASN PXDN DNAH5 INPP5E R3HCC1 ANKRD11 PRKDC SEC14L5 | 5.44e-06 | 332 | 248 | 12 | 37433992 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACP1 NAGLU MCM7 SQOR DDB1 PTGS1 NDUFS3 FASN GBP5 GLS FADS2 KIFC3 DNAH6 CALR DNAJC16 ACAD9 COX7A1 COX7A2P2 IDH2 SACM1L TGM2 CRLS1 VWA5A OGDHL POFUT1 RERE DNAJC3 | 5.90e-06 | 1451 | 248 | 27 | 30550785 |
| Pubmed | 6.10e-06 | 179 | 248 | 9 | 19074885 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CD2AP PSMC3 IREB2 MCM7 POLA2 WASHC2A DDB1 FASN ADSS2 UBE3A GLS PLCB3 MVP KPNA2 OGT NRDC CALR POLR2H NELFB SAMHD1 TGM2 MTHFD1 PA2G4 EIF5B ROCK1 PRKDC SORD | 6.20e-06 | 1455 | 248 | 27 | 22863883 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ADAM9 ACP1 NAGLU DDB1 PTGS1 CEMIP2 HSPA13 NF1 PXDN FKTN FADS2 TOR1B PLXNB1 FAT4 CALR DNAJC16 LAMA4 PIGU SACM1L TGM2 VAC14 POFUT1 DNAJC3 IL6ST | 6.22e-06 | 1201 | 248 | 24 | 35696571 |
| Pubmed | RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity. | 7.05e-06 | 6 | 248 | 3 | 35444206 | |
| Pubmed | Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. | 7.05e-06 | 6 | 248 | 3 | 12189167 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 7.30e-06 | 183 | 248 | 9 | 31932471 | |
| Pubmed | ERCC2 HSP90AB4P ADAM9 PSMC3 URB2 POLA2 HSPA13 FASN PXDN GLS TOR1B KPNA2 HAUS7 DNAJC13 NRDC CALR ACAD9 GSK3A SACM1L MTHFD1 EIF5B POFUT1 PRKDC DNAJC3 SORD | 7.35e-06 | 1297 | 248 | 25 | 33545068 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CD2AP ASH1L ARHGEF38 NDUFS3 PTPN4 PXDN KLHL23 DOCK6 UTRN RIC1 SMG6 DNAJC13 GNL3L OGT POLR1A STAP2 ARFGEF3 GCC2 ENTPD1 TTC21B ANKRD11 TANC1 RERE SPIDR CFAP69 DNAJC3 VPS13B | 9.39e-06 | 1489 | 248 | 27 | 28611215 |
| Pubmed | ERCC2 ALDH1L1 NDUFS3 NLN GLS TOR1B HAUS7 ACAD9 SAMHD1 IDH2 SACM1L VAC14 NISCH DDRGK1 OGDHL AKAP11 RHOT1 | 1.02e-05 | 686 | 248 | 17 | 28380382 | |
| Pubmed | Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. | 1.23e-05 | 7 | 248 | 3 | 1461282 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90AB4P PSMC3 MCM7 URB2 DDB1 NDUFS3 FASN NF1 ADSS2 GLS KLHL23 DNAH5 KPNA2 GNL3L POLR1A NRDC DNAH10 CALR ACAD9 SAMHD1 IDH2 SACM1L MTHFD1 PA2G4 EIF5B PRKDC | 1.25e-05 | 1425 | 248 | 26 | 30948266 |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | AMACR IREB2 DELE1 ALDH1L1 SQOR NDUFS3 NLN PHYH FASN SUOX GLS NRDC ACAD9 COX7A1 IDH2 CRLS1 MTHFD1 EHHADH OGDHL RHOT1 | 1.27e-05 | 926 | 248 | 20 | 20877624 |
| Pubmed | 1.30e-05 | 72 | 248 | 6 | 36376293 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | HSP90AB4P PSMC3 MCM7 DDB1 NDUFS3 FASN KPNA2 GNL3L POLR1A SAMHD1 IDH2 MTHFD1 NISCH PRKDC RHOT1 | 1.54e-05 | 565 | 248 | 15 | 33567341 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TEX2 CD2AP MPRIP NF1 CEP95 PPIP5K2 DOCK6 UTRN CAMKK1 INPP5E NELFB PTPN21 GSK3A ARFGEF3 RESF1 ANKRD11 AKAP11 TANC1 OTOG | 1.56e-05 | 861 | 248 | 19 | 36931259 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.61e-05 | 202 | 248 | 9 | 33005030 | |
| Pubmed | 1.61e-05 | 202 | 248 | 9 | 24639526 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ADAM9 SNX17 CEMIP2 ABCB1 NF1 PLCB3 PLXNB1 GNL3L DNAJC16 FERMT1 CSNK1G2 ROCK1 TANC1 VPS13B IL6ST | 1.68e-05 | 569 | 248 | 15 | 30639242 |
| Pubmed | PCGF2 ERG DIS3L ADAM9 ASH1L EYA3 ZEB2 MPRIP HSPA13 UBE3A GLS KIFC3 HERC2 MVP UTRN PREX1 OGT VPS39 REV3L GSK3A FBXL16 NISCH PRKDC WDFY3 | 1.88e-05 | 1285 | 248 | 24 | 35914814 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PSMC3 MCM7 PABPC5 ITIH2 MPRIP FASN PXDN MVP KPNA2 CALR SAMHD1 IDH2 SACM1L TGM2 MTHFD1 PRKDC | 1.92e-05 | 647 | 248 | 16 | 26618866 |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | MAOB AMACR IREB2 DELE1 ALDH1L1 SQOR NDUFS3 ABCB1 NLN PHYH FASN SUOX NRDC ACAD9 COX7A1 COX7A2P2 IDH2 CRLS1 MTHFD1 EHHADH RHOT1 | 2.29e-05 | 1047 | 248 | 21 | 18614015 |
| Pubmed | TEX2 ACP1 WASHC2A DDB1 NDUFS3 CEMIP2 MPRIP HSPA13 GLS FADS2 HERC2 PMS1 DNAJC13 CALR DNAJC16 ACAD9 PIGU PA2G4 NISCH ANKRD11 EIF5B DDRGK1 AKAP11 TANC1 DNAJC3 VPS13B | 2.58e-05 | 1487 | 248 | 26 | 33957083 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | PSMC3 MCM7 ALDH1L1 HSPA13 PREX1 KPNA2 IDH2 KCTD17 MTHFD1 PRKDC | 2.61e-05 | 269 | 248 | 10 | 30442662 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | HSP90AB4P ADAM9 SNX17 CEMIP2 HSPA13 NLN NF1 FADS2 TOR1B NIPA1 DOCK6 VPS39 SGCD SLC19A2 PIGU GSK3A DTWD2 MTHFD1 PRKDC WDFY3 IL6ST | 2.78e-05 | 1061 | 248 | 21 | 33845483 |
| Pubmed | PIDD orchestrates translesion DNA synthesis in response to UV irradiation. | 2.84e-05 | 25 | 248 | 4 | 21415862 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ADAM9 ACP1 CD2AP NAGLU ALDH1L1 ITIH2 ABCB1 FASN SERPINI2 PXDN ADSS2 VCAM1 MGAM FAT4 CPE IDH2 TGM2 MTHFD1 SERPINA10 IL6ST SORD | 3.14e-05 | 1070 | 248 | 21 | 23533145 |
| Pubmed | PSMC3 DDB1 MPRIP FASN KPNA2 IDH2 MTHFD1 PA2G4 NISCH EIF5B PRKDC | 3.16e-05 | 334 | 248 | 11 | 30425250 | |
| Pubmed | PSMC3 MCM7 DDB1 FASN POLR1A CALR ACAD9 POLR2H SAMHD1 IDH2 POLR3C MTHFD1 PRKDC SORD | 3.41e-05 | 534 | 248 | 14 | 35032548 | |
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 4.14e-05 | 10 | 248 | 3 | 26503718 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GALM ACP1 CD2AP NAGLU BPIFB1 ALDH1L1 DDB1 CEMIP2 ABCB1 FASN RAB43 KHK KIFC3 MVP UTRN ALOX12 DNAJC13 TGM2 MTHFD1 SORD | 4.67e-05 | 1016 | 248 | 20 | 19056867 |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ERCC2 ERCC4 ALDH1L1 PTGS1 ABCB1 SERPINI2 ALOX12 RAG1 CAMKK1 REV3L MTHFD1 | 4.94e-05 | 351 | 248 | 11 | 20453000 |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 10525423 | ||
| Pubmed | Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma. | 5.06e-05 | 2 | 248 | 2 | 20717685 | |
| Pubmed | Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice. | 5.06e-05 | 2 | 248 | 2 | 26744329 | |
| Pubmed | Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. | 5.06e-05 | 2 | 248 | 2 | 17452456 | |
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 5.06e-05 | 2 | 248 | 2 | 28790199 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 23437355 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 16566920 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 26974331 | ||
| Pubmed | Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. | 5.06e-05 | 2 | 248 | 2 | 22447074 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 12498815 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 7987307 | ||
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 5.06e-05 | 2 | 248 | 2 | 11861579 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 30575026 | ||
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 5.06e-05 | 2 | 248 | 2 | 30914715 | |
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 5.06e-05 | 2 | 248 | 2 | 17889902 | |
| Pubmed | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | 5.06e-05 | 2 | 248 | 2 | 37626761 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 23665024 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 32632164 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 26516677 | ||
| Pubmed | Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. | 5.06e-05 | 2 | 248 | 2 | 22209498 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 10694796 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 24337461 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 20827171 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 11297940 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 21854253 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 20085590 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 22388933 | ||
| Pubmed | Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress. | 5.06e-05 | 2 | 248 | 2 | 28232487 | |
| Pubmed | Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. | 5.06e-05 | 2 | 248 | 2 | 19131360 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 5.06e-05 | 2 | 248 | 2 | 36717248 | |
| Pubmed | Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis. | 5.06e-05 | 2 | 248 | 2 | 28785010 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 16307000 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 21949353 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 23097179 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 27271990 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 15501597 | ||
| Pubmed | Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy. | 5.06e-05 | 2 | 248 | 2 | 17525297 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 18973234 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 27881412 | ||
| Pubmed | Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. | 5.06e-05 | 2 | 248 | 2 | 29065908 | |
| Pubmed | Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. | 5.06e-05 | 2 | 248 | 2 | 31039133 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 34837148 | ||
| Pubmed | Dystrophin and dystrophin-related protein in the brains of normal and mdx mice. | 5.06e-05 | 2 | 248 | 2 | 8159184 | |
| Pubmed | Dystrophin and utrophin: genetic analyses of their role in skeletal muscle. | 5.06e-05 | 2 | 248 | 2 | 10679963 | |
| Pubmed | TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice. | 5.06e-05 | 2 | 248 | 2 | 21565990 | |
| GeneFamily | Dyneins, axonemal | 2.90e-07 | 17 | 160 | 5 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.03e-04 | 18 | 160 | 3 | 91 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.91e-04 | 50 | 160 | 4 | 1293 | |
| GeneFamily | WASH complex | 1.14e-03 | 6 | 160 | 2 | 1331 | |
| GeneFamily | Ring finger proteins|Polycomb group ring fingers | 1.59e-03 | 7 | 160 | 2 | 61 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 1.59e-03 | 7 | 160 | 2 | 1268 | |
| GeneFamily | RNA polymerase subunits | 2.10e-03 | 29 | 160 | 3 | 726 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 2.10e-03 | 8 | 160 | 2 | 1125 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.69e-03 | 9 | 160 | 2 | 1230 | |
| GeneFamily | Phosphoinositide phosphatases | 2.79e-03 | 32 | 160 | 3 | 1079 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.58e-03 | 115 | 160 | 5 | 769 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | PCGF2 PTGS1 ZEB2 INPP4B FASN NF1 PXDN UBE3A HERC2 PPIP5K2 KPNA2 DNAJC13 OGT NRDC CALR IDH2 REV3L POLR3C PRKDC SPIDR VPS13B RHOT1 SORD | 2.05e-06 | 790 | 248 | 23 | M12490 |
| Coexpression | ZHANG_RESPONSE_TO_CANTHARIDIN_DN | 3.35e-06 | 67 | 248 | 7 | M2510 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | ERCC4 DIS3L KLHL35 CEP95 TOR1B SMG6 HAUS7 POLR1A ATP6V1E2 CBLB PIGU | 3.51e-06 | 200 | 248 | 11 | M4313 |
| Coexpression | HALLMARK_DNA_REPAIR | 1.37e-05 | 150 | 248 | 9 | M5898 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.77e-05 | 86 | 248 | 7 | M39247 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | TRPC4 ZEB2 DUOX1 TRANK1 GBP4 GBP5 DDX60L VCAM1 SAMHD1 RSAD2 DNAH17 SERPINB2 SERPINA10 | 2.32e-05 | 339 | 248 | 13 | M34012 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | CD2AP IREB2 USP38 UTRN GNL3L DNAJC16 ARFGEF3 DTWD2 GCC2 PRKDC WDFY3 VPS13B | 1.03e-09 | 193 | 249 | 12 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | ADAM9 WASHC2A SQOR CEMIP2 SKAP2 RIC1 DNAJC13 WASHC2C NRDC SAMHD1 VCAN | 1.50e-08 | 196 | 249 | 11 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | TLR8 ZEB2 GBP4 GBP5 DDX60L SKAP2 PREX1 MGAM NRDC RESF1 CSF2RB | 1.58e-08 | 197 | 249 | 11 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ADAM9 ZEB2 FADS2 VCAM1 NAALAD2 COL6A6 LAMA4 TGM2 MOXD1 VCAN IL6ST | 1.76e-08 | 199 | 249 | 11 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-08 | 169 | 249 | 10 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | AMACR SERPINI2 KCNH2 KLHL23 RPS6KA6 SCNN1B FAT4 COX7A1 MOXD1 OGDHL | 4.40e-08 | 170 | 249 | 10 | b465df2dac6b4e98b4ede6ad0c6347656757885c |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-08 | 184 | 249 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-08 | 184 | 249 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-08 | 184 | 249 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-07 | 188 | 249 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | ESRP1 ARHGEF38 C8orf34 DUOX1 FASN CFAP221 SCNN1B DNAH5 MBIP ARFGEF3 | 1.13e-07 | 188 | 249 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 189 | 249 | 10 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 189 | 249 | 10 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.25e-07 | 190 | 249 | 10 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-07 | 190 | 249 | 10 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | PRTG ESRP1 ARHGEF38 C8orf34 ADCY8 DUOX1 FASN CFAP221 MBIP ARFGEF3 | 1.31e-07 | 191 | 249 | 10 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-07 | 191 | 249 | 10 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-07 | 191 | 249 | 10 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-07 | 192 | 249 | 10 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | PRTG ESRP1 ARHGEF38 C8orf34 ADCY8 DUOX1 FASN CFAP221 MBIP ARFGEF3 | 1.38e-07 | 192 | 249 | 10 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | TRANK1 GLS HERC2 CELF6 GNL3L ZWINT CNNM1 FBXL16 AKAP11 ATP2B2 | 1.52e-07 | 194 | 249 | 10 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | BPIFB1 C8orf34 CFAP221 DNAH5 DNAH6 DNAH10 ARFGEF3 DNAH12 TANC1 CFAP69 | 1.59e-07 | 195 | 249 | 10 | fce0c29574bb7aab181b9c00feb42681e285d1f2 |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | BPIFB1 C8orf34 CFAP221 DNAH5 DNAH6 DNAH10 ARFGEF3 DNAH12 TANC1 CFAP69 | 1.59e-07 | 195 | 249 | 10 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-07 | 196 | 249 | 10 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 1.67e-07 | 196 | 249 | 10 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.67e-07 | 196 | 249 | 10 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-07 | 197 | 249 | 10 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TTLL9 C8orf34 CFAP221 DMD DNAH5 DNAH6 DNAH10 BBS5 DNAH12 CFAP69 | 1.75e-07 | 197 | 249 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.92e-07 | 199 | 249 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.01e-07 | 200 | 249 | 10 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-07 | 200 | 249 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.01e-07 | 200 | 249 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.01e-07 | 200 | 249 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-07 | 159 | 249 | 9 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-07 | 177 | 249 | 9 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.49e-07 | 183 | 249 | 9 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.49e-07 | 183 | 249 | 9 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.93e-07 | 184 | 249 | 9 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ESRP1 ARHGEF38 C8orf34 CFAP221 SCNN1B DMD DNAH5 MBIP ARFGEF3 | 1.09e-06 | 186 | 249 | 9 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 186 | 249 | 9 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-06 | 190 | 249 | 9 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | TTLL9 C8orf34 DUOX1 CFAP221 DNAH5 PLXNB1 DNAH10 ARFGEF3 DNAH12 | 1.35e-06 | 191 | 249 | 9 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 191 | 249 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.35e-06 | 191 | 249 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 191 | 249 | 9 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 191 | 249 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | TTLL9 C8orf34 DUOX1 CFAP221 DNAH5 PLXNB1 DNAH10 ARFGEF3 DNAH12 | 1.35e-06 | 191 | 249 | 9 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 192 | 249 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | TTLL9 C8orf34 SERPINI2 CFAP221 DNAH5 DNAH6 DNAH10 DNAH12 CFAP69 | 1.41e-06 | 192 | 249 | 9 | 354adc1354bf596fbc60dd45c0169688e6f45165 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-06 | 193 | 249 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | C8orf34 SERPINI2 CFAP221 DMD DNAH5 DNAH6 DNAH10 DNAH12 CFAP69 | 1.48e-06 | 193 | 249 | 9 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 195 | 249 | 9 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.61e-06 | 195 | 249 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 195 | 249 | 9 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 195 | 249 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | BPIFB1 C8orf34 CFAP221 DNAH5 DNAH6 DNAH10 ARFGEF3 DNAH12 CFAP69 | 1.61e-06 | 195 | 249 | 9 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 1.68e-06 | 196 | 249 | 9 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.68e-06 | 196 | 249 | 9 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.68e-06 | 196 | 249 | 9 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 1.68e-06 | 196 | 249 | 9 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.75e-06 | 197 | 249 | 9 | 143607d195c8aa2b94d995af0b2ef38582565611 | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 1.75e-06 | 197 | 249 | 9 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.75e-06 | 197 | 249 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 198 | 249 | 9 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 1.82e-06 | 198 | 249 | 9 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 199 | 249 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-06 | 199 | 249 | 9 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 199 | 249 | 9 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-06 | 199 | 249 | 9 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.90e-06 | 199 | 249 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.90e-06 | 199 | 249 | 9 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-06 | 148 | 249 | 8 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 249 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Sigmoid-(1)_T_cell-(17)_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 1.98e-06 | 200 | 249 | 9 | a02e5a69f7101accd8f1394ab1c8007e211187f7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 249 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 249 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sigmoid-T_cell-gd_T|Sigmoid / Region, Cell class and subclass | 1.98e-06 | 200 | 249 | 9 | eef4df008cccdf6297b1c90c986c68793afd8b78 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 249 | 9 | a3f22826f3d8f917ff0594bdadd93b60763bcaa2 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | ESRP1 ARHGEF38 DUOX1 FASN CFAP221 SCNN1B DNAH5 PLXNB1 ARFGEF3 | 1.98e-06 | 200 | 249 | 9 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 249 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 249 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 249 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-06 | 164 | 249 | 8 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 164 | 249 | 8 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-06 | 164 | 249 | 8 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.10e-06 | 169 | 249 | 8 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-06 | 169 | 249 | 8 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.10e-06 | 169 | 249 | 8 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.32e-06 | 170 | 249 | 8 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 172 | 249 | 8 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 176 | 249 | 8 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 176 | 249 | 8 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-06 | 177 | 249 | 8 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.46e-06 | 178 | 249 | 8 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 178 | 249 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.66e-06 | 130 | 249 | 7 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.66e-06 | 130 | 249 | 7 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.78e-06 | 182 | 249 | 8 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.44e-05 | 49 | 161 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Oxidoreductases. | MAOB ALDH1L1 NDUFS3 PHYH FASN FADS2 COX7A1 IDH2 MTHFD1 EHHADH SORD | 8.92e-05 | 182 | 161 | 11 | MODULE_93 |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | ITIH2 NF1 KHK DOCK6 NAALAD2 STON1 LAMA4 PTPN21 KCTD17 VWA5A VCAN SPIDR CFAP69 | 2.63e-07 | 198 | 246 | 13 | 3700_DN |
| Drug | NSC236997 | NAGLU IREB2 DDB1 PTGS1 ZEB2 ADCY8 DUOX1 FASN GLS RPS6KA6 ALOX12 VCAM1 MGAM OGT GPX5 STAP2 VCAN ROCK1 SERPINA10 PRKDC SORD | 4.65e-07 | 539 | 246 | 21 | CID000005300 |
| Drug | Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | ERCC2 MAOB PTGS1 KCNH6 NF1 SCNN1B NAALAD2 TGM2 POFUT1 PRKG2 SPIDR CFAP69 | 1.68e-06 | 197 | 246 | 12 | 2274_UP |
| Drug | WAY-123,398 | 2.65e-06 | 10 | 246 | 4 | CID000132160 | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.64e-06 | 193 | 246 | 11 | 2842_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | MYO9B PTPN21 GSK3A CLDN9 VWA5A ENTPD1 RERE WDFY3 SPIDR VPS13B IL6ST | 9.53e-06 | 195 | 246 | 11 | 3392_DN |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | MAOB MYO9B CHRNB3 NF1 KCNH2 FADS2 PTPN21 KCTD17 MOXD1 PRKG2 CFAP69 | 1.00e-05 | 196 | 246 | 11 | 5668_UP |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; HL60; HG-U133A | MGAM CALR DNAJC16 INPP5E STAP2 MBIP VAC14 RERE WDFY3 SPIDR IL6ST | 1.05e-05 | 197 | 246 | 11 | 1972_UP |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | MYO9B PTGS1 TRANK1 NF1 GLS KIFC3 MGAM GSK3A DNAH17 POFUT1 PRKG2 | 1.05e-05 | 197 | 246 | 11 | 3514_UP |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | ERCC4 ARHGEF38 EYA3 NF1 PLXNB1 CALR RNPEPL1 PTPN21 GSK3A SERPINB2 IL6ST | 1.05e-05 | 197 | 246 | 11 | 6747_DN |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | ERCC2 ERCC4 AMACR PTGS1 ITIH2 NF1 GLS VCAN ENTPD1 POFUT1 VPS13B | 1.05e-05 | 197 | 246 | 11 | 2267_UP |
| Drug | Flupenthixol | 1.23e-05 | 5 | 246 | 3 | ctd:D005475 | |
| Drug | magnesium | ERCC2 ACP1 POLA2 ADCY8 INPP4B ABCB1 NUDT12 NF1 ADSS2 KCNH2 DNAH5 RAG1 MGAM DNAH10 POLR2H SLC19A2 COX7A1 LAMA4 ACTRT2 IDH2 NLRP14 MTHFD1 CSNK1G2 GCC2 VCAN DNAH17 ENTPD1 LPIN2 EIF5B ROCK1 EXOC2 ATP2B2 | 1.74e-05 | 1325 | 246 | 32 | CID000000888 |
| Drug | Glafenine | GALE GALM MAOB TEX2 AMACR PSMC3 ALDH1L1 SQOR CEMIP2 ABCB1 HSPA13 NUDT12 FASN ADSS2 SUOX FADS2 KHK VCAM1 PLXNB1 KPNA2 WASHC2C CALR ACAD9 RNPEPL1 STAP2 CRLS1 MTHFD1 EHHADH PA2G4 SERPINA10 DNAJC3 SORD | 1.79e-05 | 1327 | 246 | 32 | ctd:D005897 |
| Drug | Doxazosin | 2.43e-05 | 6 | 246 | 3 | DB00590 | |
| Drug | Prazosin | 2.43e-05 | 6 | 246 | 3 | DB00457 | |
| Drug | Terazosin | 2.43e-05 | 6 | 246 | 3 | DB01162 | |
| Drug | NSC20261 | ERCC2 POLA2 GLS SMG6 POLR1A POLR2H NELFB REV3L POLR3C ENTPD1 SERPINA10 | 3.46e-05 | 224 | 246 | 11 | CID000000593 |
| Drug | sterculic acid | 4.22e-05 | 7 | 246 | 3 | CID000012921 | |
| Drug | N-ethylmaleimide | MYO9B ADCY8 ABCB1 PTPN4 CLC GLS KIFC3 SMG6 ATP6V1E2 ACTRT2 IDH2 REV3L AKTIP NLRP14 ENTPD1 LHFPL5 ATP2B2 | 4.48e-05 | 511 | 246 | 17 | CID000004362 |
| Drug | MK-499 | 4.54e-05 | 19 | 246 | 4 | CID000127718 | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | ALDH1L1 TLR8 TRANK1 KCNH2 SMG6 NAALAD2 LAMA4 GSK3A POFUT1 CFAP69 | 5.23e-05 | 194 | 246 | 10 | 4951_UP |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | ERCC4 ARHGEF38 NAALAD2 SGCD LAMA4 GSK3A TGM2 OGDHL WDFY3 IL6ST | 5.23e-05 | 194 | 246 | 10 | 2223_UP |
| Drug | CNDAC | 5.62e-05 | 20 | 246 | 4 | CID000119184 | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | MYO9B ZEB2 UBE3A SKAP2 DNAJC16 R3HCC1 TGM2 VAC14 EIF5B DNAJC3 | 5.70e-05 | 196 | 246 | 10 | 379_UP |
| Drug | UTP-NA | ERCC2 GALE POLA2 ADCY8 GLS PLCB3 VCAM1 POLR1A POLR2H NELFB POLR3C NLRP14 ENTPD1 ROCK1 ATP2B2 | 5.73e-05 | 420 | 246 | 15 | CID000001181 |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | ARHGEF38 CLCN1 KCNH2 KIFC3 PLXNB1 KCTD17 TGM2 VWA5A ENTPD1 OGDHL | 5.95e-05 | 197 | 246 | 10 | 4403_UP |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.21e-05 | 198 | 246 | 10 | 2771_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | MAOB SERPINI2 UTRN PLXNB1 RAG1 NAALAD2 SGCD GSK3A ATP2B2 VPS13B | 6.21e-05 | 198 | 246 | 10 | 4765_UP |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.21e-05 | 198 | 246 | 10 | 2316_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | CHRNB3 DUOX1 KCNH2 KHK RAG1 TGM2 VWA5A POFUT1 VPS13B SEC14L5 | 6.48e-05 | 199 | 246 | 10 | 3566_UP |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | PTGS1 CHRNB3 TRANK1 KCNH2 KIFC3 VWA5A RERE PRKG2 ATP2B2 VPS13B | 6.48e-05 | 199 | 246 | 10 | 1509_UP |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 6.48e-05 | 199 | 246 | 10 | 5544_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.48e-05 | 199 | 246 | 10 | 2298_UP | |
| Drug | niflumic acid | 6.57e-05 | 125 | 246 | 8 | CID000004488 | |
| Drug | Miconazole | 6.70e-05 | 8 | 246 | 3 | DB01110 | |
| Drug | Risperidone | 7.26e-05 | 65 | 246 | 6 | ctd:D018967 | |
| Drug | myo-inositol | TPTE TEX2 TRPC4 ADCY8 INPP4B CHRNB3 NF1 USP38 PLCB3 PPIP5K2 PREX1 ALOX12 POLR1A CALR INPP5E GRM3 GSK3A CRX CRLS1 NISCH ATP2B2 SORD | 7.57e-05 | 811 | 246 | 22 | CID000000892 |
| Drug | mM Q | 7.71e-05 | 41 | 246 | 5 | CID000445446 | |
| Drug | UDP-glucose | GALE GALM ACP1 NAGLU B3GALT5 VCAM1 MGAM OGT CALR VPS13B SORD | 8.35e-05 | 247 | 246 | 11 | CID000001166 |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 1.07e-05 | 6 | 242 | 3 | DOID:0050427 (implicated_via_orthology) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.37e-05 | 21 | 242 | 4 | DOID:9884 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TPTE TRPC4 ARHGEF38 PTGS1 ZEB2 NDUFS3 INPP4B ABCB1 FASN NF1 CLCN1 FKTN SCNN1B HERC2 DMD PLXNB1 VPS39 CRX TGM2 NLRP14 NISCH SERPINB2 VPS13B | 2.90e-05 | 1074 | 242 | 23 | C0006142 |
| Disease | egg allergy measurement | 4.41e-05 | 9 | 242 | 3 | EFO_0007018 | |
| Disease | long QT syndrome (implicated_via_orthology) | 6.27e-05 | 10 | 242 | 3 | DOID:2843 (implicated_via_orthology) | |
| Disease | Hematologic Neoplasms | 1.13e-04 | 12 | 242 | 3 | C0376545 | |
| Disease | mean fractional anisotropy measurement | 1.35e-04 | 95 | 242 | 6 | EFO_0008399 | |
| Disease | short QT syndrome (implicated_via_orthology) | 2.00e-04 | 3 | 242 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1L (implicated_via_orthology) | 2.00e-04 | 3 | 242 | 2 | DOID:0110436 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (implicated_via_orthology) | 2.00e-04 | 3 | 242 | 2 | DOID:627 (implicated_via_orthology) | |
| Disease | suntan | 2.11e-04 | 103 | 242 | 6 | EFO_0004279 | |
| Disease | Colorectal Carcinoma | ERCC2 AMACR ALDH1L1 C8orf34 ZEB2 ADCY8 ABCB1 NF1 SCNN1B FADS2 DMD CALR RNPEPL1 CPE TGM2 IL6ST | 2.47e-04 | 702 | 242 | 16 | C0009402 |
| Disease | Ciliopathies | 3.01e-04 | 110 | 242 | 6 | C4277690 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 3.40e-04 | 17 | 242 | 3 | OBA_2045063 | |
| Disease | Schizophrenia | MAOB MYO9B AMACR ACP1 PTGS1 ABCB1 KCNH6 ADSS2 KCNH2 FADS2 ALOX12 VPS39 PTPN21 GRM3 GSK3A TGM2 CSF2RB MTHFD1 | 3.94e-04 | 883 | 242 | 18 | C0036341 |
| Disease | Liposarcoma, Pleomorphic | 3.98e-04 | 4 | 242 | 2 | C0205825 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 3.98e-04 | 4 | 242 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Congenital myotonia | 3.98e-04 | 4 | 242 | 2 | cv:CN295225 | |
| Disease | epilepsy (implicated_via_orthology) | 4.12e-04 | 163 | 242 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 4.22e-04 | 215 | 242 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 4.63e-04 | 44 | 242 | 4 | C0340427 | |
| Disease | Leukemia, Myelocytic, Acute | 5.88e-04 | 173 | 242 | 7 | C0023467 | |
| Disease | Malignant neoplasm of prostate | ERCC2 ERG AMACR ADAM9 NAGLU ASH1L PMS1 RAG1 CALR CLDN9 EHHADH PRKDC DNAJC3 IL6ST | 6.16e-04 | 616 | 242 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | ERCC2 ERG AMACR ADAM9 NAGLU ASH1L PMS1 RAG1 CALR CLDN9 EHHADH PRKDC DNAJC3 IL6ST | 6.16e-04 | 616 | 242 | 14 | C0033578 |
| Disease | Bipolar Disorder | MAOB ADCY8 CHRNB3 TRANK1 FADS2 ALOX12 CALR GRM3 GSK3A TGM2 MTHFD1 EHHADH | 6.26e-04 | 477 | 242 | 12 | C0005586 |
| Disease | acute myeloid leukemia (is_implicated_in) | 6.49e-04 | 84 | 242 | 5 | DOID:9119 (is_implicated_in) | |
| Disease | dual specificity mitogen-activated protein kinase kinase 1 measurement | 6.59e-04 | 5 | 242 | 2 | EFO_0020335 | |
| Disease | Joubert syndrome with ocular defect | 6.59e-04 | 5 | 242 | 2 | C4274118 | |
| Disease | cholestasis (biomarker_via_orthology) | 7.00e-04 | 49 | 242 | 4 | DOID:13580 (biomarker_via_orthology) | |
| Disease | otitis media (implicated_via_orthology) | 7.48e-04 | 22 | 242 | 3 | DOID:10754 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | MYO9B ADCY8 TRANK1 NF1 KCNH2 RAB43 FADS2 PLCB3 KPNA2 MGAM DNAH10 INPP5E R3HCC1 GPX5 SAMHD1 PIGU FBXL16 KANK3 ANKRD11 PRKG2 | 8.52e-04 | 1106 | 242 | 20 | EFO_0021796 |
| Disease | waist circumference | ALDH1L1 SQOR ADCY8 FASN DMD DNAH5 PREX1 DNAH10 TEX11 CBLB MOXD1 | 8.97e-04 | 429 | 242 | 11 | EFO_0004342 |
| Disease | liposarcoma | 9.83e-04 | 6 | 242 | 2 | C0023827 | |
| Disease | Liposarcoma, well differentiated | 9.83e-04 | 6 | 242 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 9.83e-04 | 6 | 242 | 2 | C0205824 | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 9.83e-04 | 6 | 242 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | lipopolysaccharide-binding protein measurement | 9.83e-04 | 6 | 242 | 2 | EFO_0021894 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 9.83e-04 | 6 | 242 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | basal cell carcinoma | 9.89e-04 | 189 | 242 | 7 | EFO_0004193 | |
| Disease | Peripheral Nervous System Diseases | 1.01e-03 | 54 | 242 | 4 | C4721453 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.29e-03 | 145 | 242 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Cerebellar Diseases | 1.37e-03 | 7 | 242 | 2 | C0007760 | |
| Disease | Vitiligo | 1.49e-03 | 101 | 242 | 5 | EFO_0004208 | |
| Disease | Psychotic Disorders | 1.49e-03 | 101 | 242 | 5 | C0033975 | |
| Disease | Obesity | 1.58e-03 | 205 | 242 | 7 | C0028754 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.60e-03 | 61 | 242 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Strabismus | 1.70e-03 | 29 | 242 | 3 | HP_0000486 | |
| Disease | Muscular Dystrophy | 1.82e-03 | 8 | 242 | 2 | C0026850 | |
| Disease | memory impairment | 1.82e-03 | 8 | 242 | 2 | EFO_0001072 | |
| Disease | Primary familial dilated cardiomyopathy | 1.88e-03 | 30 | 242 | 3 | cv:C0340427 | |
| Disease | Disorder of eye | 1.91e-03 | 212 | 242 | 7 | C0015397 | |
| Disease | Liver Cirrhosis, Experimental | PRTG AMACR ALDH1L1 PTGS1 ZEB2 CEMIP2 ABCB1 PXDN GBP4 GLS SKAP2 MVP PAMR1 SLC19A2 AKTIP | 1.95e-03 | 774 | 242 | 15 | C0023893 |
| Disease | mean platelet volume | DIS3L MYO9B TEX2 CD2AP MPRIP TXK TRANK1 GLS FADS2 MVP ALOX12 PCDHGC4 NRDC COL6A6 RNPEPL1 GCC2 ANKRD11 SEC14L5 | 2.01e-03 | 1020 | 242 | 18 | EFO_0004584 |
| Disease | mean corpuscular hemoglobin concentration | ERG MYO9B IREB2 URB2 ZEB2 CHRNB3 RAB43 FADS2 PLCB3 PREX1 DNAJC13 STON1 POLR1A WASHC2C RNPEPL1 KCTD17 PRKDC EXOC2 VPS13B | 2.03e-03 | 1105 | 242 | 19 | EFO_0004528 |
| Disease | lower face morphology measurement | 2.08e-03 | 109 | 242 | 5 | EFO_0010948 | |
| Disease | tuberculosis | 2.12e-03 | 216 | 242 | 7 | MONDO_0018076 | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.27e-03 | 32 | 242 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | Xeroderma pigmentosum | 2.32e-03 | 9 | 242 | 2 | cv:C0043346 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 2.32e-03 | 9 | 242 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Abdominal Aortic Aneurysm | 2.38e-03 | 68 | 242 | 4 | EFO_0004214 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.38e-03 | 68 | 242 | 4 | EFO_0022327 | |
| Disease | ovarian cancer (is_marker_for) | 2.38e-03 | 68 | 242 | 4 | DOID:2394 (is_marker_for) | |
| Disease | joint hypermobility measurement | 2.48e-03 | 33 | 242 | 3 | EFO_0007905 | |
| Disease | internet addiction disorder | 2.48e-03 | 33 | 242 | 3 | EFO_0803368 | |
| Disease | Primary dilated cardiomyopathy | 2.70e-03 | 34 | 242 | 3 | cv:C0007193 | |
| Disease | triacylglycerol 58:10 measurement | 2.70e-03 | 34 | 242 | 3 | EFO_0010437 | |
| Disease | Asthma, Occupational | 2.89e-03 | 10 | 242 | 2 | C0264423 | |
| Disease | FEV/FEC ratio | ARHGEF38 IREB2 MCM7 ZEB2 ADCY8 INPP4B CEMIP2 PTPN4 SUOX SKAP2 DNAH5 SMG6 KPNA2 MGAM MBIP DNAH12 ANKRD11 POFUT1 EXOC2 LRRC37B | 2.90e-03 | 1228 | 242 | 20 | EFO_0004713 |
| Disease | differentiated thyroid carcinoma | 2.94e-03 | 35 | 242 | 3 | EFO_1002017 | |
| Disease | Testicular Germ Cell Tumor | 3.09e-03 | 73 | 242 | 4 | EFO_1000566 | |
| Disease | urate measurement | SNX17 ESRP1 ASH1L INPP4B USP38 FADS2 PLCB3 ATP8B3 DNAJC13 DNAJC16 COX7A2P2 IDH2 PIGU POLR3C NISCH SORD | 3.10e-03 | 895 | 242 | 16 | EFO_0004531 |
| Disease | meningitis | 3.51e-03 | 11 | 242 | 2 | MONDO_0021108 | |
| Disease | Basal cell carcinoma | 3.51e-03 | 11 | 242 | 2 | C0007117 | |
| Disease | cataract (implicated_via_orthology) | 3.72e-03 | 38 | 242 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | Acute Myeloid Leukemia, M1 | 3.76e-03 | 125 | 242 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.76e-03 | 125 | 242 | 5 | C1879321 | |
| Disease | platelet component distribution width | MYO9B CD2AP INPP4B MPRIP TXK TRANK1 FADS2 PREX1 RNPEPL1 TEX11 KCTD17 GCC2 ENTPD1 SEC14L5 | 4.03e-03 | 755 | 242 | 14 | EFO_0007984 |
| Disease | Intellectual Disability | 4.05e-03 | 447 | 242 | 10 | C3714756 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.05e-03 | 447 | 242 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 4.19e-03 | 12 | 242 | 2 | EFO_0800453 | |
| Disease | melanoma | 4.54e-03 | 248 | 242 | 7 | C0025202 | |
| Disease | Cutaneous Melanoma | 4.62e-03 | 41 | 242 | 3 | C0151779 | |
| Disease | Anorectal Malformations | 4.62e-03 | 41 | 242 | 3 | C3495676 | |
| Disease | Epilepsy, Cryptogenic | 4.68e-03 | 82 | 242 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 4.68e-03 | 82 | 242 | 4 | C0751111 | |
| Disease | Aura | 4.68e-03 | 82 | 242 | 4 | C0236018 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 4.92e-03 | 13 | 242 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 4.92e-03 | 13 | 242 | 2 | C0751198 | |
| Disease | smoking status measurement, ulcerative colitis | 4.92e-03 | 13 | 242 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 4.92e-03 | 13 | 242 | 2 | OBA_2045159 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 4.92e-03 | 13 | 242 | 2 | OBA_2045174 | |
| Disease | Hepatic Encephalopathy | 4.92e-03 | 13 | 242 | 2 | C0019151 | |
| Disease | Hepatic Coma | 4.92e-03 | 13 | 242 | 2 | C0019147 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 4.92e-03 | 13 | 242 | 2 | OBA_2045082 | |
| Disease | rectum cancer | 4.94e-03 | 42 | 242 | 3 | EFO_1000657 | |
| Disease | Breast Carcinoma | PTGS1 ZEB2 NDUFS3 INPP4B ABCB1 FASN HERC2 VPS39 TGM2 NISCH SERPINB2 | 5.14e-03 | 538 | 242 | 11 | C0678222 |
| Disease | sleep measurement | 5.21e-03 | 135 | 242 | 5 | EFO_0004870 | |
| Disease | serum iron measurement | 5.54e-03 | 86 | 242 | 4 | EFO_0006332 | |
| Disease | serum alanine aminotransferase measurement | CD2AP ALDH1L1 ABCB1 MPRIP TRANK1 KLHL23 FADS2 TOR1B CELF6 STON1 STAP2 CDCP2 PIGU RESF1 SORD | 5.68e-03 | 869 | 242 | 15 | EFO_0004735 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 5.71e-03 | 14 | 242 | 2 | DOID:6419 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQPELLSSYKEGLLD | 246 | Q14146 | |
| GIQYFEKLNPDFLLE | 436 | Q7Z4L5 | |
| QVPEETYLILKDQGF | 1131 | P40145 | |
| LKYFLEALCGQEEPL | 1131 | Q86US8 | |
| TVLVFYLPSDEGEKL | 251 | Q05901 | |
| YVLGFKIDPVEKLQE | 231 | Q8N3I7 | |
| TKEPLKAGQFIIEYL | 2161 | Q9NR48 | |
| AAIVDAIKLDAIEPY | 2416 | Q6UB99 | |
| EFDLLYPAIKGDTIQ | 231 | Q8TDL5 | |
| TEIELFPYSGDKILV | 651 | P13611 | |
| EEVLREYKLPDGNII | 236 | Q8TDY3 | |
| PGYQVKVFFLDLDLE | 291 | Q5VXM1 | |
| LDLYQLAVEKGDPQL | 116 | Q9BXU8 | |
| IEPQFYELLIKGLGL | 236 | Q9UHK6 | |
| EVFLQIKGPLEDIYK | 171 | Q9NXL2 | |
| ILDDLYGPIAFKDFI | 346 | A6NHR8 | |
| AVKEYGLPDVNILLF | 146 | P11308 | |
| IDEINKDDYLLPGVK | 76 | Q14832 | |
| LFPGVYEEQGEIILK | 136 | Q9UK96 | |
| IFPDGQLYIKSELDR | 1046 | Q6V0I7 | |
| IAYFKNKELEQGEPL | 401 | Q9BQL6 | |
| LKSLGLFGLQVPEEY | 101 | Q9H845 | |
| PEAAVLYEKDIQLFK | 196 | Q9H8T0 | |
| QAYLEKNKIGPLFEE | 96 | Q49A92 | |
| VPYIKLEDVFVGLCL | 236 | Q9Y2C3 | |
| PVIFLDEEGYQKSLK | 316 | Q9UKA4 | |
| AGVALYPKEITLEAF | 301 | Q8TC27 | |
| KPELYVVGQKDELFN | 1061 | O60423 | |
| LFEYIPQNEDELELK | 116 | Q9Y5K6 | |
| IFLTEQPLEGLEKLY | 2871 | P11532 | |
| FEESKDNTIPLLYGI | 96 | Q96NB1 | |
| YKLPDNVTFEEGALI | 141 | Q00796 | |
| LYPGAEAANLEEFIL | 151 | Q8NBA8 | |
| PFLLVLVDLQYEGAE | 16 | Q13217 | |
| DLKPLFEEFGRIYEL | 61 | Q96J87 | |
| KQKLFQEDDGIPLYL | 31 | O60397 | |
| KLFQEDNDIPLYLKG | 31 | P24310 | |
| GKFIYITPEELAAVA | 266 | Q96HY6 | |
| VKYGDLLPADGLFIQ | 216 | Q01814 | |
| GVLAYELLPALDEVL | 596 | P54802 | |
| GLPYAATIEDILDFL | 451 | Q6NXG1 | |
| EIYDFEPALKTEDLL | 321 | Q9Y3T6 | |
| LDDYLNGPFTVVVKE | 586 | P15918 | |
| PDEQYDFLFKLVLVG | 11 | Q86YS6 | |
| IYPLAVLFEDALVLG | 776 | Q4ADV7 | |
| AKVLLYGLGEIFPIE | 491 | Q99504 | |
| AELYQKEGIPLIILA | 831 | P48200 | |
| EAILKVYEEGFVKPL | 906 | P29074 | |
| DLLFYTIAEGQEKIP | 141 | O94925 | |
| GLFVPAILLVNYAKD | 266 | O95907 | |
| AILLVNYAKDAGVPD | 271 | O95907 | |
| QLLERFYDPLAGKVL | 1081 | P08183 | |
| YNLKLLLNGEPELDV | 201 | Q86VD1 | |
| ELYAKVLGSLEALEP | 366 | P27338 | |
| IPKEYDLVLLFNLEE | 706 | Q9NRD9 | |
| YELTPNELFGLEIKT | 166 | Q8TAB3 | |
| LLQPFNVLYEKEGEF | 301 | Q9UQ80 | |
| GIEYQEKPLLRALLD | 411 | O95864 | |
| SPLAQGKDAYELEVL | 891 | Q6WCQ1 | |
| KVLEYLAKVNDIAPG | 216 | Q9BZ81 | |
| NIPLAAGKFDRELYL | 601 | Q9NRR6 | |
| DYEDLVELAPGKFQL | 31 | P19823 | |
| LVKGLPEALQRQFEY | 3816 | O95714 | |
| QVLSLGADVLPEYKL | 376 | Q9NS40 | |
| PQFIGCLIAVYLEKE | 181 | Q58FF6 | |
| PAEDNLYLVFDLLRK | 221 | Q8N5S9 | |
| LKDALYDVITVGAPA | 356 | O15327 | |
| QLYDVLIKKNPFGIE | 1081 | O43451 | |
| AFVLGYRQDKLLPDD | 196 | Q8TAF8 | |
| IIDFGLAKEYIDPET | 186 | P78368 | |
| QVLSLGADVLPEYKL | 376 | Q12809 | |
| VLSLGADVLPEYKLQ | 226 | Q9H252 | |
| QDIVYKLVPGLFKNE | 76 | P35226 | |
| VILAELPEDFKAALY | 1496 | Q5H9U9 | |
| NIPDLSIYLKGDVFD | 756 | Q13191 | |
| QAYFLLEEGSKPEEV | 491 | Q08426 | |
| AAEFEVPKLVQYLEI | 336 | Q8N3Y1 | |
| PVPLAVKYFFDLLDE | 1946 | O43157 | |
| ENYIELKADPIVGSL | 761 | Q96KP1 | |
| LPLILVGNKSDLVEY | 111 | Q8IXI2 | |
| LIKQEAEKYPGAELA | 926 | Q9ULD0 | |
| IQLLKDGYRLDEIPD | 141 | Q8IW50 | |
| FILLGYLDQLRKDPA | 476 | Q9Y2G8 | |
| ESGLLAEQYPKLLFD | 3006 | Q6ZR08 | |
| LFGDEVSPLLKQYIL | 156 | Q8WX92 | |
| GQEFELSISVLPDKY | 86 | Q05315 | |
| LYNITDGIDPDLLVF | 116 | A6NHS7 | |
| LNFYEKQEGEKLPFL | 91 | P18074 | |
| EVPGDDYKNKLIFAI | 896 | Q96QE4 | |
| EDEYLENALKLIPGK | 211 | Q96PP9 | |
| DIFGPLEEAVKQGIY | 411 | Q96PP8 | |
| YRDLKPENILLDEIG | 196 | Q9UK32 | |
| LFYQRDDIVKGDPEL | 481 | P18054 | |
| KLTLLGPLDFESENY | 301 | Q9Y5F7 | |
| DIDALEFYPGLLLEK | 496 | P23219 | |
| KALPENVKYGIVLDA | 41 | P49961 | |
| EAEFYNIGPLIRIIK | 111 | Q8N5Z5 | |
| KLLLELDQYAPDVAE | 111 | Q9H490 | |
| GIIYRDLKPENLILD | 571 | Q13237 | |
| VGAYLPAVFEEVLDL | 201 | Q14764 | |
| LFADAVQELLPQYKE | 76 | P33993 | |
| PEDLKGFLSYLEEIQ | 1071 | Q16825 | |
| QENGPIFLDTKDLLY | 661 | Q2VWP7 | |
| FRDLVIKYGAVDPLL | 196 | P52292 | |
| QDIVYKLVPGLFKDE | 76 | P35227 | |
| LKAALYVGDLDPDVT | 16 | Q96DU9 | |
| SIFGDALLIEPLDKY | 431 | Q01970 | |
| ELLEAGYLPVVIDNF | 21 | Q14376 | |
| VLGFAELEGYLQKQP | 56 | Q96C23 | |
| AIDLEYFLNKPIIFG | 2361 | Q9C0G6 | |
| PGDLEFEVVYKRLQD | 166 | P32927 | |
| ILPHVDIQLKYFDLG | 71 | P48735 | |
| PFEANGKILDYEVTL | 356 | P40189 | |
| KDELYLNLVLEYVPE | 186 | P49840 | |
| INIDIDPVYLKTALG | 226 | Q8NBE8 | |
| EIEIEPIFGILALYD | 271 | Q96HP0 | |
| YGIPDLKIDLAAQYI | 2831 | Q9UFH2 | |
| GEDEFKDLPYLELLV | 201 | A2VCK2 | |
| VVQERFGPELKYDIA | 316 | Q14CM0 | |
| FGPELKYDIALRLAA | 321 | Q14CM0 | |
| VQDYLEILEFPELKG | 66 | Q8TF46 | |
| QNLYDILLEEFVKGP | 1726 | Q5TH69 | |
| EQFGRIYELTVLKDP | 66 | Q8N6W0 | |
| EIEKIRPGFEEQILY | 186 | Q8IWJ2 | |
| LLGLAVAEPAVYFKE | 11 | P27797 | |
| FPDLDRIVYVNEKEG | 191 | P16870 | |
| KDLNCPFLEGLYITE | 36 | Q99871 | |
| LERNKDLLPEDFVVY | 81 | Q13443 | |
| FIALYQSILGEKVPD | 36 | Q96GE4 | |
| LGVLEQFIPLQLDEY | 1346 | Q9UHN6 | |
| IIPYSKDVDLGIFIQ | 311 | O75072 | |
| EPLEFEQYLNLRFGK | 211 | O75165 | |
| KILELEGISPEYFQS | 281 | Q9NS73 | |
| LDFLKYIEELERGPA | 46 | Q6NY19 | |
| EVEKPREELFQLFGY | 171 | P50053 | |
| ELEAEIGRYPFKVLN | 111 | P48723 | |
| ELNALQEELKPYGLV | 81 | O75715 | |
| EPLFLAQAEVYKELR | 981 | P49327 | |
| PKLEKAEILEFAVGY | 51 | Q9BYE0 | |
| KIYAILGKLDFENLP | 721 | A5D8W1 | |
| DVLQILEEFYNIFGP | 476 | Q8IVF4 | |
| LEEFYNIFGPELKAV | 481 | Q8IVF4 | |
| ETKYLEQLGFTVPEL | 676 | Q8IVF4 | |
| LVDYLDREVIPDFLG | 461 | O43304 | |
| YLLGPDKNLTEREVF | 56 | O60779 | |
| IILYNGKDFVDAPRL | 566 | Q9NTJ5 | |
| KLILDIGQEDYVPFL | 296 | P51168 | |
| ELEEKLTNPVFVGYL | 151 | Q7RTP0 | |
| CLPFYGVADLKEILN | 841 | P54277 | |
| QKIYGADDIELLPEA | 831 | P11586 | |
| LEELEALFAKTQYPD | 51 | O43186 | |
| APVLGYLIIEEDFNI | 121 | Q9UJA2 | |
| YDGLFKVIPLDRDNK | 136 | Q16531 | |
| IKPDGEYLELFARNL | 431 | Q8N3J2 | |
| VRFGALKYADDPEVL | 846 | A6NMZ7 | |
| FLGVLFTKEPYLDEQ | 356 | Q14154 | |
| NILLDKAGYPELEAA | 2211 | Q8TE73 | |
| LRLKPDFIDGYINLA | 116 | O15294 | |
| NYDPILLDADIAILK | 551 | Q6UXH9 | |
| FPVVLEQLDDYNAKL | 471 | Q16363 | |
| IEDLKAQILELPYAG | 246 | P05120 | |
| YEENGFLVIKNLVPD | 61 | O14832 | |
| QAGDVLLFDQYKIIP | 586 | Q6ZRI0 | |
| SLKPEVAQVDLYILG | 331 | Q9H488 | |
| YKLDRGDPILDEEFQ | 406 | Q4G0U5 | |
| LYNVLPGGEKEFVNL | 146 | Q8N461 | |
| YLGIEKLLDPEDVAV | 221 | P46939 | |
| LDYLPEILDGLFQIL | 211 | Q08AM6 | |
| AYLVALVAGDLKPAD | 256 | Q9HAU8 | |
| NRVILAEFDYKAEPL | 386 | Q9Y6N5 | |
| LVPFLLDEDYEKVLG | 241 | Q9UGK3 | |
| DVYPFDRLEIDLLKG | 141 | P19320 | |
| EGINLPELFKYAEVL | 1581 | O95602 | |
| EPFLQDRGEYLGKLV | 126 | Q8WXG1 | |
| QYGLIPEEDICFIKE | 256 | Q9Y3Z3 | |
| PLEKDLEIQLYDFDL | 1546 | A0AVI2 | |
| VLYKEGERDFLQLPG | 256 | O75019 | |
| AQDLPFVLKAGYLEK | 111 | O75563 | |
| SELLKEFPYGIEAVN | 1056 | Q9HCM1 | |
| ASEFLGQLVKLDPVY | 761 | A6NCM1 | |
| EIYNEVLRDLLGKEP | 576 | Q9BVG8 | |
| TLAGLPLLVAYKEDE | 941 | O60841 | |
| QEVYLDKFIRLLDAP | 291 | Q9NVN8 | |
| KQLSAFGEYVAEILP | 56 | O75489 | |
| LLGSYDPQKQLIIED | 116 | P24666 | |
| LFVYEKGARVLLVPD | 151 | Q9H6Y7 | |
| LLILPQEEDYGFDIE | 626 | Q8TCU6 | |
| KIPEEEYIILIDGLN | 581 | Q9C0D5 | |
| DYLAQPEKITLIFLG | 186 | Q9BQG2 | |
| EGISEFLLPLYVKEI | 81 | Q96LD1 | |
| YPTLEIDIEGELQKL | 206 | P30520 | |
| ELLPNKETGELITFY | 421 | Q9P2R6 | |
| IVPLGISYIDDFAKE | 141 | G3V0H7 | |
| VDLSELKEYSLFPGQ | 286 | Q14181 | |
| YGKPLVFDLREEDLF | 476 | A8MXQ7 | |
| LPDVVAKYQALGAEL | 66 | O75891 | |
| DFYNPLVAEALKREL | 146 | O95484 | |
| FPDGILFDDIIYKIL | 506 | P35523 | |
| RPVDYFVLLLQGKVE | 666 | Q9NRU3 | |
| KEYFPIEVVTEGLLN | 381 | Q9BYT8 | |
| DLYLENPEIKIRILG | 581 | P21980 | |
| VAAKLDLPDDLIGYF | 146 | Q15036 | |
| PHLKVLDLEFNYLVG | 311 | Q9NR97 | |
| LYTLQGKLLFPEAEA | 216 | O95229 | |
| KILIDVFDGLPLYDD | 461 | P56180 | |
| GIRKDPFLYEADVQV | 26 | Q9H900 | |
| PVLYQSLKDLLEYEG | 656 | Q05086 | |
| ADVKELIPEFFYLPE | 2841 | Q8IZQ1 | |
| YLTLLADDPLEFVGK | 311 | Q9BUI4 | |
| YLKEEQTILPGDNLI | 426 | Q6UVY6 | |
| YQPAAELGKDLIDLA | 41 | Q9NXB0 | |
| NIIKRYDPDILLGYE | 2391 | O60673 | |
| YEQGLEKPFKEIQLD | 311 | Q9Y6Q2 | |
| LGQIDIIDEDPIYKL | 611 | Q14159 | |
| LKLEGDSEFLQPLYA | 76 | Q92629 | |
| KLQELEQEYGEPFLA | 131 | Q9BSI4 | |
| TYFLPVIGLVDAEKL | 131 | P17980 | |
| DLEVYLQKLLAAFPG | 91 | Q9Y2I1 | |
| IPSGAFEDLENLKYL | 101 | Q92626 | |
| FLEFENSEGYPLLLK | 306 | Q6ZS81 | |
| NVKDLVGLELSPALY | 916 | P21359 | |
| IVKFLDALIDTYLPG | 2731 | P21359 | |
| LTGDQLLFEYKPEVI | 581 | O43847 | |
| LLFEYKPEVIGEALN | 586 | O43847 | |
| LLYEFEVRAKLNDPL | 741 | Q8IYF3 | |
| YKGDEFSLIIILPAE | 241 | O75830 | |
| TLKYVQELPLEADGA | 126 | O00534 | |
| NGRVELILEPKDLYI | 166 | Q9Y4E1 | |
| QIYPVDLGDKFRLVI | 46 | P52434 | |
| FPDLYEPILEAIKDF | 391 | Q8NB14 | |
| KVEFLRNELEIPGQY | 3691 | P78527 | |
| EIPKIFQILYANEGE | 1191 | Q13464 | |
| LYLKANPEELVVFED | 106 | P98182 | |
| FDEINPETKLILVDY | 221 | Q9UK55 | |
| AEEKIQVKALYDFLP | 81 | P42681 | |
| NGRVELILEPKDLYI | 166 | Q641Q2 | |
| ELYGYDILIDQDLKP | 321 | Q3SXZ7 | |
| EEELGLLDPAQRKLY | 41 | Q9UK13 | |
| QDAESLKLPGVYEVL | 2311 | Q7Z7G8 | |
| LLAQYKIGELNPEDK | 151 | P51687 | |
| PAEEEYFINQLKIEG | 66 | Q92889 | |
| LSKALADIVIPQEYG | 751 | O43314 | |
| GLLKIKTEPLDFNDY | 386 | O60315 | |
| LGDVFSIIQEYKPKD | 2456 | O15050 | |
| EVIYEPFQLLSKIIG | 296 | Q8IWB9 | |
| PKLQFEDFIDRVEYL | 116 | Q9BVW5 | |
| EIYFKININCIDPLG | 56 | Q9UBN4 | |
| DKNLIDYFIPFLPLE | 266 | O14657 | |
| FLIENFKGLAIPYLE | 591 | Q96JC1 | |
| VEDPEVYQGLLDKLV | 106 | Q96A05 | |
| LLAPAYFLEKVEADE | 246 | Q6PF15 | |
| DDLKGLEPEVAALYF | 406 | Q92539 | |
| PDFGLLLYLEELNKE | 11 | Q86W24 | |
| GALVYELVDSKIIPF | 571 | Q9Y3Q0 | |
| AQYGDFLRAVELPEK | 1786 | Q13459 |